Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001056868-02-000010
Filing Date
2002-07-10
Accepted
2002-07-10 14:45:44
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT 2 - BELOW 5% neot13ga2.txt SC 13G/A 12330
  Complete submission text file 0001056868-02-000010.txt   14438
Mailing Address 157 TECHNOLOGY DR STE J-821 IRVINE CA 92618
Business Address 157 TECHNOLOGY DR STE J-821 IRVINE CA 92618 9497886700
NEOTHERAPEUTICS INC (Subject) CIK: 0000831547 (see all company filings)

EIN.: 930979187 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-49329 | Film No.: 02699845
SIC: 2834 Pharmaceutical Preparations

Mailing Address 601 UNION STREET SUITE 3900 SEATTLE WA 98101
Business Address 601 UNION STREET SUITE 3900 SEATTLE WA 98101 2064476200
SUMMIT CAPITAL MANAGEMENT LLC (Filed by) CIK: 0001056868 (see all company filings)

EIN.: 911723315 | State of Incorp.: WA | Fiscal Year End: 1231